Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The safety profile in humans is yet to be fully established, and interested parties should consult with healthcare professionals before considering its use
BPC-157 has been thoroughly researched for its therapeutic potential in a variety of conditions, including musculoskeletal injuries, digestive disorders, neurological conditions, autoimmune diseases, and skin and soft tissue injuries
Mechanism, dosing, evidence, and what the research does not yet support
Plasma levels of GHK-Cu decline significantly with age, from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, a 60% reduction that correlates closely with the age-related decline in regenerative capacity
US$ 26.82
US$ 22.10
US$ 26.95
US$ 24.82
US$ 24.49
